PROJECT 2 The proposed project describes a comprehensive research plan to develop and apply automated field- deployable lab-on-a-chip nanosensing platforms with high throughput, sensitivity and efficiency for multi- functional analysis of hazardous substances relevant to health and environmental monitoring in the Superfund Research Center (SRC). As extensive human activities pose increased environmental challenges worldwide, modern environmental monitoring and analytical technologies become particularly important to protect human health from adverse exposure to industrial pollutants, and to considerably improve public awareness. However, conventional laboratory-based analytical instruments are typically expensive and bulky, and require elaborate operational procedures conducted by dedicated personnel. The objective of this work is to deliver field- deployable multipurpose lab-on-a-chip technologies enabled by emerging microfluidics and nanosensing technologies for application in environmental monitoring and human health. Specifically, two innovative technological platforms to be investigated are: 1) a microfluidic print-to-analyze (MPA) system for high- throughput high-sensitivity biomolecular analysis (Aim I), and 2) a field-deployable ELISA-on-a-chip platform to incorporate quantitative nanosensing molecular assays (Aims II-IV), from which a 3D printable device can be customized and interfaced with mobile devices for health and environmental monitoring. Upon development, these technologies are expected to facilitate multiplexed, quantitative, automated processing and analysis of human biospecimens and environmental samples, with high sensitivity, quick turnover at low cost. Initial studies will involve testing these devices to detect pesticides and their degradation products, as an identified high concern for our community partner. More broadly, these platforms will be easily adaptable to commercial biorecognition molecules and detection of numerous Superfund priority chemicals. Overall, this research project directly advances the NIEHS mandate to develop analytical tools for the detection of hazardous chemicals and to apply them to environmental and human health monitoring applications.

Public Health Relevance

PROJECT 2 The proposed project describes a comprehensive research plan to develop and apply automated field- deployable lab-on-a-chip platforms with high throughput, high sensitivity and high efficiency for multifunctional analysis of hazardous substances relevant to human health, environmental monitoring, and the Superfund Research Program stakeholders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Hazardous Substances Basic Research Grants Program (NIEHS) (P42)
Project #
5P42ES004699-31
Application #
9683902
Study Section
Special Emphasis Panel (ZES1)
Project Start
Project End
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
31
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Taha, Ameer Y; Hennebelle, Marie; Yang, Jun et al. (2018) Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid. Prostaglandins Leukot Essent Fatty Acids 138:71-80
Hill 3rd, Thomas; Rice, Robert H (2018) DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate. Toxicol In Vitro 46:257-264
Kodani, Sean D; Wan, Debin; Wagner, Karen M et al. (2018) Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega 3:14076-14086
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Napimoga, M H; Rocha, E P; Trindade-da-Silva, C A et al. (2018) Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption. J Periodontal Res 53:743-749
Blöcher, René; Wagner, Karen M; Gopireddy, Raghavender R et al. (2018) Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain. J Med Chem 61:3541-3550
Hao, Lei; Kearns, Jamie; Scott, Sheyenne et al. (2018) Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther 365:467-475

Showing the most recent 10 out of 1149 publications